- Report
- March 2025
- 250 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- February 2025
- 200 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- November 2024
- 150 Pages
Global
From €2918EUR$3,250USD£2,485GBP
€4355EUR$4,850USD£3,708GBP
- Report
- June 2025
- 466 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 78 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 168 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 192 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 181 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 376 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 103 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 192 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 213 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 224 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 577 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 419 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 466 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- February 2025
- 200 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- April 2025
- 147 Pages
Global
From €2693EUR$2,999USD£2,293GBP
- Report
- August 2024
- 136 Pages
Global
From €2693EUR$2,999USD£2,293GBP
- Report
- April 2025
- 185 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP

Prodrugs are a type of biotechnology that involves the modification of a drug molecule to improve its pharmacokinetic properties. This is done by making the drug more soluble, increasing its absorption, or making it more stable in the body. Prodrugs are designed to be more effective and safer than the original drug, and can be used to treat a variety of diseases.
Prodrugs are used in a variety of therapeutic areas, including cancer, cardiovascular disease, and infectious diseases. They are also used to improve the delivery of drugs to specific tissues or organs, and to reduce the side effects of drugs.
The prodrug market is growing rapidly, driven by the increasing demand for more effective and safer drugs. The market is expected to continue to grow in the coming years, as more companies develop and launch new prodrugs.
Some companies in the prodrug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more